Ultralife (NASDAQ:ULBI - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at Benchmark in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $14.00 price objective on the technology company's stock. Benchmark's price objective points to a potential upside of 90.22% from the stock's previous close.
Separately, StockNews.com lowered shares of Ultralife from a "strong-buy" rating to a "buy" rating in a research note on Thursday, October 3rd.
Check Out Our Latest Stock Report on ULBI
Ultralife Price Performance
ULBI stock traded down $0.31 during midday trading on Friday, reaching $7.36. 102,931 shares of the stock were exchanged, compared to its average volume of 79,956. The company has a fifty day moving average price of $8.97 and a 200 day moving average price of $10.25. Ultralife has a 52 week low of $6.36 and a 52 week high of $13.39. The stock has a market capitalization of $122.40 million, a PE ratio of 13.38 and a beta of 0.98. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.30 and a quick ratio of 2.06.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Quadrature Capital Ltd acquired a new position in Ultralife during the 1st quarter valued at about $200,000. Empowered Funds LLC grew its holdings in Ultralife by 7.8% during the first quarter. Empowered Funds LLC now owns 31,396 shares of the technology company's stock worth $277,000 after buying an additional 2,275 shares in the last quarter. O Shaughnessy Asset Management LLC purchased a new stake in Ultralife in the 1st quarter valued at $100,000. Hillsdale Investment Management Inc. bought a new position in Ultralife during the 1st quarter valued at $166,000. Finally, Vanguard Group Inc. boosted its holdings in Ultralife by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company's stock worth $4,545,000 after acquiring an additional 6,640 shares during the last quarter. Institutional investors own 30.68% of the company's stock.
Ultralife Company Profile
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Featured Articles
Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
